financetom
Business
financetom
/
Business
/
Colonial allocates Cycle 32 shipments on distillate Line 20
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Colonial allocates Cycle 32 shipments on distillate Line 20
May 24, 2024 5:23 AM

May 24 (Reuters) - Colonial Pipeline Co is

allocating space for Cycle 32 shipments on Line 20, which

carries distillates from Atlanta to Nashville, Tennessee, the

company said in a notice sent to shippers on Friday.

* Committed information will be available on May 28, the

pipeline

operator said.

* The company generally announces allocations when

nominations, or

requests, for space to ship petroleum products on its lines

exceed its ability to meet the five-day lifting cycle.

* The cycles are five-day periods when a sequence of all

in-season

products is pumped.

* Colonial pumps the same sequence of products every five

days.

* Colonial connects U.S. Gulf Coast refineries with markets

across

the southern and eastern United States through more than 5,500

miles (8,850 kms) of pipeline, delivering gasoline, diesel, jet

fuel and other refined products.

(Reporting by Daksh Grover in Bengaluru

Editing by David Goodman

)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Quanterix To Acquire Akoya Biosciences
BRIEF-Quanterix To Acquire Akoya Biosciences
Jan 10, 2025
Jan 10 (Reuters) - Akoya Biosciences Inc ( AKYA ): * QUANTERIX TO ACQUIRE AKOYA BIOSCIENCES, CREATING THE FIRST INTEGRATED SOLUTION FOR ULTRA-SENSITIVE DETECTION OF BLOOD- AND TISSUE-BASED PROTEIN BIOMARKERS * QUANTERIX TO ACQUIRE AKOYA BIOSCIENCES, CREATING THE FIRST INTEGRATED SOLUTION FOR ULTRA-SENSITIVE DETECTION OF BLOOD- AND TISSUE-BASED PROTEIN BIOMARKERS * QUANTERIX CORP ( QTRX ) - TO ACQUIRE AKOYA...
Intra-Cellular Therapies, Sandoz Settle CAPLYTA Patent Litigation
Intra-Cellular Therapies, Sandoz Settle CAPLYTA Patent Litigation
Jan 10, 2025
07:36 AM EST, 01/10/2025 (MT Newswires) -- Intra-Cellular Therapies ( ITCI ) said Friday it reached a settlement with Sandoz to resolve patent litigation over its central nervous system disorder drug CAPLYTA. The settlement allows Sandoz to sell generic versions of CAPLYTA starting July 1, 2040, or earlier under specific conditions, the company said. The litigation stemmed from Sandoz's Abbreviated...
NeoGenomics Appoints Tony Zook as CEO
NeoGenomics Appoints Tony Zook as CEO
Jan 10, 2025
07:34 AM EST, 01/10/2025 (MT Newswires) -- NeoGenomics ( NEO ) said Friday it appointed Tony Zook, an independent board member, to succeed Chris Smith as chief executive officer. Smith will retire from his position, effective April 1, but will stay on as an advisor during the transition to ensure continuity and knowledge transfer, the company said. Zook is a...
Activist Barington urges manufacturer TriMas to consider sale of company
Activist Barington urges manufacturer TriMas to consider sale of company
Jan 10, 2025
* Barington steps up pressure on TriMas ( TRS ) by now pushing for a broader review * Barington says time is right to hire adviser with CEO planning to exit * More activists are expected to include M&A demands this year By Svea Herbst-Bayliss NEW YORK, Jan 10 (Reuters) - Activist investor Barington Capital Group wants TriMas ( TRS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved